| 摘要 |
The present invention concerns protection of an organ or tissue following an ischemic episode In particular aspects, the invention concerns organ pre servation for transplantation, angina pectoris, kidney reperfusion injury, a nd so forth In specific embodiments, the organ is subjected to an inhibitor of an NCCa-ATP channel that is regulated by SURl Exemplary inhibitors includ e sulfonylurea compounds, such as glibenclamide, for example |
